Denmark's Novo Nordisk and South Africa's Aspen to produce insulin for African patients
Published
Last year, the World Health Organization estimated that there are 24 million adults living with diabetes in Africa, saying the number is expected to rise to 55 million by 2045. Danish pharmaceutical company Novo Nordisk has signed a deal with South Africa's Aspen Pharmacare to produce human…
#africa #danish #novonordisk #southafrica #pharmacare #gqeberha #african